Biocytogen’s RenMab™ Mouse is featured in the Nov. Issue of Genetic Engineering & Biotechnology News (GEN). Read the full article here.
RenMab™ Mouse highlights:
- Developed upon Biocytogen’s unique Mb-scale chromosome engineering technology
- Variable regions of heavy chain and k light chain are replaced by human counterparts in situ
- Constant region is retained to ensure proper B cell development
- Normal response to immunization
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry.